肺癌筛查时点戒烟干预对美国肺癌及总死亡率潜在影响
该研究利用已建立的肺癌模拟模型,比较在筛查合格人群中仅年度筛查与增加一次戒烟干预对死亡率的影响。模型输入来自国家数据,纳入吸烟史、戒烟概率、肺癌风险与治疗有效性等。结果显示戒烟可降低肺癌死亡率并延迟总死亡,其获益幅度随筛查使用率、戒烟效果和出生队列变化。
要点
- 在筛查合格人群中,增加戒烟干预较仅筛查可降低肺癌死亡率并增加生命年。
- 戒烟获益幅度受筛查使用率、戒烟干预效果和出生队列影响。
- 需评估具体戒烟干预的成本与实施可行性以优化筛查项目。
核心结论
- 戒烟干预有潜力大幅增强肺癌筛查项目的影响。
研究设计与样本
- 采用已建立的肺癌模拟模型,比较假设的一次性戒烟干预联合年度筛查与仅年度筛查对死亡率的影响。
- 研究对象为出生于1950年或1960年的筛查合格个体。
- 模型输入来自国家数据,包括吸烟史、有无干预的戒烟概率、肺癌风险与治疗有效性及竞争性烟草相关死亡。
主要发现
- 在所有假设下,戒烟较仅筛查降低肺癌死亡率并延迟总死亡。
- 若筛查使用率为30%的1950年出生筛查合格个体,增加戒烟概率为10%的干预,较仅筛查降低肺癌死亡14%并增加生命年81%。
- 戒烟获益幅度随筛查使用率、戒烟效果和出生队列变化。
临床怎么用
- 对符合筛查条件的现吸烟者,在肺癌筛查时点应提供戒烟干预。
- 开展肺癌筛查项目时需考虑将戒烟干预整合入筛查流程。
局限性
- 结果为基于模拟模型的假设性干预分析,需评估具体干预的成本与实施可行性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Annual lung cancer screening with low-dose computed tomography is recommended for adults aged 55 to 80 years with a greater than or equal to 30 pack-year smoking history who currently smoke or quit within the past 15 years. The 50% who are current smokers should be offered cessation interventions, but information about the impact of adding cessation to screening is limited. METHODS: We used an established lung cancer simulation model to compare the effects on mortality of a hypothetical one-time cessation intervention and annual screening versus annual screening only among screen-eligible individuals born in 1950 or 1960. Model inputs were derived from national data and included smoking history, probability of quitting with and without intervention, lung cancer risk and treatment effectiveness, and competing tobacco-related mortality. We tested the sensitivity of results under different assumptions about screening use and cessation efficacy. RESULTS: Smoking cessation reduces lung cancer mortality and delays overall deaths versus screening only across all assumptions. For example, if screening was used by 30% of screen-eligible individuals born in 1950, adding an intervention with a 10% quit probability reduces lung cancer deaths by 14% and increases life years gained by 81% compared with screening alone. The magnitude of cessation benefits varied under screening uptake rates, cessation effectiveness, and birth cohort. CONCLUSIONS: Smoking cessation interventions have the potential to greatly enhance the impact of lung cancer screening programs. Evaluation of specific interventions, including costs and feasibility of implementation and dissemination, is needed to determine the best possible strategies and realize the full promise of lung cancer screening.
引用
- Cao P, Jeon J, Levy DT, et al. Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States. J Thorac Oncol. 2020. PMID: 32160967. doi:10.1016/j.jtho.2020.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。